Media

This has been anything but a typical NFL offseason for me. If you follow me on either Instagram or Twitter, you know I recently undertook an intensive, six-week brain treatment protocol at the Brain Treatment Center where I live in San Diego. It’s an affiliate of the USC Center for Neurorestoration, a progressive brain health clinic focusing on the intersection of physics and neuroscience. Read...

Wave Neuro announces the completion of an asset purchase from Newport Brain Research Laboratory (NBRL). In June 2019, Wave Neuroscience purchased substantially all of the assets from the many different onshore and offshore holding companies under NBRL. Now a wholly owned and operated U.S. corporation chartered in Delaware, Wave Neuroscience is focused on leadership in brain health and its restoration. Read the rest here...

“We are very excited to add NeoSync’s complementary IP and products to our rapidly growing suite of technologies,” said Fred Walke, CEO of Wave. “This acquisition further exemplifies our commitment to creating and optimizing what others are now realizing is possible: targeted and personalized neuromodulation that honors an individual’s unique physiology more closely than the one-size-fits-all approach commonly used today. We find especially compelling...

As part of their policy suggestions, the authors of this paper recommend Wave Neuro’s technology as the sole suggested modality for treating TBI. Click this link to read the whole report Wave Neuro's technology is featured on pages 17 & 42.

Learn more about our clinical trial with SOCOM here

The dynamic collaboration between SOC-F, TCS, and BTC San Diego offers a unique opportunity for service members struggling with symptoms such as lack of focus, chronic sleep disruption, and cognitive fog. Over the next 18 months, this collaboration will facilitate treatment by BTC San Diego of Special Operations Forces (SOF) veterans. SOC-F and TCS will bring valuable resources to support BTC San Diego’s pioneering...

“This collaboration has allowed us to study the effectiveness of MeRT,” said U.S. Navy Capt. Scott Cota, the principal investigator of the study assigned to USSOCOM. “This technology has proven safe and highly effective for the treatment of medication resistant depression, and our studies aim to validate MeRT effectiveness for treating symptoms of PTS.” Read more by clicking here

The tech Erik and his team pioneered involves using computational analytics to solve problems that have never been tackled before in the mental health space and doing it with no medications of any kind. Listen to the podcast by clicking here

Listen here

In this pilot study, MeRT demonstrated promising outcomes for treatment of PTSD. With subjects showing improvements in areas of motivation, alertness, energy level, focus, recall, ability to find words and mental acuity. Read the study by clicking here